Valerie Rusch
#54,856
Most Influential Person Now
Researcher
Valerie Rusch's AcademicInfluence.com Rankings
Valerie Ruschmedical Degrees
Medical
#477
World Rank
#653
Historical Rank
Surgery
#60
World Rank
#90
Historical Rank
Valerie Ruschphilosophy Degrees
Philosophy
#3659
World Rank
#5871
Historical Rank
Logic
#1367
World Rank
#2102
Historical Rank
Download Badge
Medical Philosophy
Why Is Valerie Rusch Influential?
(Suggest an Edit or Addition)According to Wikipedia, Valerie W Rusch, MD, FACS, is an American thoracic surgeon who is currently the Miner Family Chair for Intrathoracic Cancers and Vice Chair for Clinical Research, Department of Surgery, at Memorial Sloan Kettering Cancer Center.
Valerie Rusch's Published Works
Number of citations in a given year to any of this author's works
Total number of citations to an author for the works they published in a given year. This highlights publication of the most important work(s) by the author
Published Works
- Comprehensive molecular profiling of lung adenocarcinoma (2014) (4095)
- The IASLC Lung Cancer Staging Project: Proposals for the Revision of the TNM Stage Groupings in the Forthcoming (Seventh) Edition of the TNM Classification of Malignant Tumours (2007) (3431)
- International Association for the Study of Lung Cancer/American Thoracic Society/European Respiratory Society International Multidisciplinary Classification of Lung Adenocarcinoma (2011) (3193)
- Comprehensive genomic characterization of squamous cell lung cancers (2012) (2998)
- CTCAE v3.0: development of a comprehensive grading system for the adverse effects of cancer treatment. (2003) (2387)
- MET amplification occurs with or without T790M mutations in EGFR mutant lung tumors with acquired resistance to gefitinib or erlotinib (2007) (1619)
- Neoadjuvant PD‐1 Blockade in Resectable Lung Cancer (2018) (1203)
- Radiotherapy plus chemotherapy with or without surgical resection for stage III non-small-cell lung cancer: a phase III randomised controlled trial (2009) (1199)
- Characterizing the cancer genome in lung adenocarcinoma (2007) (1122)
- Incidence of local recurrence and second primary tumors in resected stage I lung cancer. (1995) (972)
- The IASLC Lung Cancer Staging Project: A Proposal for a New International Lymph Node Map in the Forthcoming Seventh Edition of the TNM Classification for Lung Cancer (2009) (938)
- Concurrent cisplatin/etoposide plus chest radiotherapy followed by surgery for stages IIIA (N2) and IIIB non-small-cell lung cancer: mature results of Southwest Oncology Group phase II study 8805. (1995) (860)
- Impact of proposed IASLC/ATS/ERS classification of lung adenocarcinoma: prognostic subgroups and implications for further revision of staging based on analysis of 514 stage I cases (2011) (833)
- 7th Edition of the AJCC Cancer Staging Manual: Esophagus and Esophagogastric Junction (2010) (753)
- Bronchioloalveolar pathologic subtype and smoking history predict sensitivity to gefitinib in advanced non-small-cell lung cancer. (2004) (750)
- The nuclear deubiquitinase BAP1 is commonly inactivated by somatic mutations and 3p21.1 losses in malignant pleural mesothelioma (2011) (611)
- International Association for the Study of Lung Cancer/American Thoracic Society/European Respiratory Society: international multidisciplinary classification of lung adenocarcinoma: executive summary. (2011) (600)
- An endoscopic biopsy protocol can differentiate high-grade dysplasia from early adenocarcinoma in Barrett's esophagus. (1993) (596)
- Morbidity and mortality of major pulmonary resections in patients with early-stage lung cancer: initial results of the randomized, prospective ACOSOG Z0030 trial. (2006) (584)
- A proposed new international TNM staging system for malignant pleural mesothelioma. From the International Mesothelioma Interest Group. (1995) (584)
- Randomized trial of mediastinal lymph node sampling versus complete lymphadenectomy during pulmonary resection in the patient with N0 or N1 (less than hilar) non-small cell carcinoma: results of the American College of Surgery Oncology Group Z0030 Trial. (2011) (565)
- Localization of bronchial intraepithelial neoplastic lesions by fluorescence bronchoscopy. (1998) (561)
- Extrapleural pneumonectomy versus pleurectomy/decortication in the surgical management of malignant pleural mesothelioma: results in 663 patients. (2008) (548)
- Differential expression of the epidermal growth factor receptor and its ligands in primary non-small cell lung cancers and adjacent benign lung. (1993) (516)
- The International Association for the Study of Lung Cancer Lung Cancer Staging Project: Proposals for the Revision of the N Descriptors in the Forthcoming 8th Edition of the TNM Classification for Lung Cancer (2015) (480)
- A phase II trial of surgical resection and adjuvant high-dose hemithoracic radiation for malignant pleural mesothelioma. (2001) (476)
- The IASLC Lung Cancer Staging Project: Proposals for Coding T Categories for Subsolid Nodules and Assessment of Tumor Size in Part‐Solid Tumors in the Forthcoming Eighth Edition of the TNM Classification of Lung Cancer (2016) (443)
- Cancer of the esophagus and esophagogastric junction (2010) (432)
- Overexpression of the epidermal growth factor receptor and its ligand transforming growth factor alpha is frequent in resectable non-small cell lung cancer but does not predict tumor progression. (1997) (429)
- Prospective Comprehensive Molecular Characterization of Lung Adenocarcinomas for Efficient Patient Matching to Approved and Emerging Therapies. (2017) (412)
- Optimum Lymphadenectomy for Esophageal Cancer (2010) (400)
- Patterns of surgical care of lung cancer patients. (2005) (398)
- High-intensity sequencing reveals the sources of plasma circulating cell-free DNA variants (2019) (397)
- Multicenter phase II trial of neoadjuvant pemetrexed plus cisplatin followed by extrapleural pneumonectomy and radiation for malignant pleural mesothelioma. (2009) (381)
- Lobectomy by video-assisted thoracic surgery (VATS) versus thoracotomy for lung cancer. (2009) (379)
- Thymoma: a multivariate analysis of factors predicting survival. (1995) (379)
- Induction chemoradiation and surgical resection for superior sulcus non-small-cell lung carcinomas: long-term results of Southwest Oncology Group Trial 9416 (Intergroup Trial 0160). (2007) (377)
- The impact of complications on outcomes after resection for esophageal and gastroesophageal junction carcinoma. (2004) (372)
- Preoperative F-18 fluorodeoxyglucose-positron emission tomography maximal standardized uptake value predicts survival after lung cancer resection. (2004) (362)
- The IASLC Lung Cancer Staging Project: Proposals for the Revision of the N Descriptors in the Forthcoming Seventh Edition of the TNM Classification for Lung Cancer (2007) (361)
- Lung Adenocarcinoma: Modification of the 2004 WHO Mixed Subtype to Include the Major Histologic Subtype Suggests Correlations Between Papillary and Micropapillary Adenocarcinoma Subtypes, EGFR Mutations and Gene Expression Analysis (2008) (359)
- Worldwide esophageal cancer collaboration. (2009) (351)
- Integrative Molecular Characterization of Malignant Pleural Mesothelioma. (2018) (340)
- Whole body 18FDG-PET and the response of esophageal cancer to induction therapy: results of a prospective trial. (2003) (340)
- Pathological response after neoadjuvant chemotherapy in resectable non-small-cell lung cancers: proposal for the use of major pathological response as a surrogate endpoint. (2014) (312)
- A Grading System of Lung Adenocarcinomas Based on Histologic Pattern is Predictive of Disease Recurrence in Stage I Tumors (2010) (301)
- Morbidity and mortality after neoadjuvant therapy for lung cancer: the risks of right pneumonectomy. (2001) (297)
- Initial Analysis of the International Association For the Study of Lung Cancer Mesothelioma Database (2012) (296)
- The role of extrapleural pneumonectomy in malignant pleural mesothelioma. A Lung Cancer Study Group trial. (1991) (291)
- Results of the American College of Surgeons Oncology Group Z0050 trial: the utility of positron emission tomography in staging potentially operable non-small cell lung cancer. (2003) (289)
- Homozygous deletion of CDKN2A and codeletion of the methylthioadenosine phosphorylase gene in the majority of pleural mesotheliomas. (2003) (277)
- Lung resection for colorectal metastases. 10-year results. (1992) (275)
- Robotic assistance for video-assisted thoracic surgical lobectomy: technique and initial results. (2006) (274)
- Results of chest wall resection and reconstruction with and without rigid prosthesis. (2006) (273)
- Treatment of Malignant Pleural Mesothelioma: American Society of Clinical Oncology Clinical Practice Guideline. (2018) (267)
- Induction chemoradiation and surgical resection for non-small cell lung carcinomas of the superior sulcus: Initial results of Southwest Oncology Group Trial 9416 (Intergroup Trial 0160). (2001) (265)
- The IASLC Lung Cancer Staging Project: Proposals for the Inclusion of Broncho-Pulmonary Carcinoid Tumors in the Forthcoming (Seventh) Edition of the TNM Classification for Lung Cancer (2008) (262)
- Lung cancer — major changes in the American Joint Committee on Cancer eighth edition cancer staging manual (2017) (257)
- Staging of malignant pleural mesothelioma: comparison of CT and MR imaging. (1999) (257)
- Incidence of EGFR exon 19 deletions and L858R in tumor specimens from men and cigarette smokers with lung adenocarcinomas. (2011) (255)
- Role of video-assisted thoracic surgery in the treatment of pulmonary metastases: results of a prospective trial. (1996) (251)
- Prognostic and Therapeutic Implications of EGFR and KRAS Mutations in Resected Lung Adenocarcinoma (2008) (248)
- Important prognostic factors in patients with malignant pleural mesothelioma, managed surgically. (1999) (247)
- Mesothelioma: Scientific clues for prevention, diagnosis, and therapy (2019) (246)
- Use of video-assisted thoracic surgery for lobectomy in the elderly results in fewer complications. (2008) (246)
- Pleurodesis using talc slurry. (1994) (245)
- Visceral Pleural Invasion: Pathologic Criteria and Use of Elastic Stains: Proposal for the 7th Edition of the TNM Classification for Lung Cancer (2008) (235)
- Patterns of recurrence and second primary lung cancer in early-stage lung cancer survivors followed with routine computed tomography surveillance. (2013) (233)
- Global gene expression profiling of pleural mesotheliomas: overexpression of aurora kinases and P16/CDKN2A deletion as prognostic factors and critical evaluation of microarray-based prognostic prediction. (2006) (229)
- Recommendations for Uniform Definitions of Surgical Techniques for Malignant Pleural Mesothelioma: A Consensus Report of the International Association for the Study of Lung Cancer International Staging Committee and the International Mesothelioma Interest Group (2011) (224)
- An integrated genomic analysis of lung cancer reveals loss of DUSP4 in EGFR-mutant tumors (2009) (223)
- Adenocarcinoma of the Gastroesophageal Junction: Influence of Esophageal Resection Margin and Operative Approach on Outcome (2007) (220)
- Impact of micropapillary histologic subtype in selecting limited resection vs lobectomy for lung adenocarcinoma of 2cm or smaller. (2013) (219)
- Use of cigarette-smoking history to estimate the likelihood of mutations in epidermal growth factor receptor gene exons 19 and 21 in lung adenocarcinomas. (2006) (217)
- Genetic Predictors of Response to Systemic Therapy in Esophagogastric Cancer. (2018) (214)
- Proposed revision of the staging classification for esophageal cancer. (1998) (213)
- Novel MEK1 mutation identified by mutational analysis of epidermal growth factor receptor signaling pathway genes in lung adenocarcinoma. (2008) (212)
- Long-term Survival Based on the Surgical Approach to Lobectomy For Clinical Stage I Nonsmall Cell Lung Cancer: Comparison of Robotic, Video-assisted Thoracic Surgery, and Thoracotomy Lobectomy (2017) (211)
- The prognostic importance of the number of involved lymph nodes in esophageal cancer: implications for revisions of the American Joint Committee on Cancer staging system. (2006) (211)
- Coexistence of PIK3CA and Other Oncogene Mutations in Lung Adenocarcinoma–Rationale for Comprehensive Mutation Profiling (2011) (210)
- Aberrant p53 expression predicts clinical resistance to cisplatin-based chemotherapy in locally advanced non-small cell lung cancer. (1995) (208)
- Promising survival with three-dimensional conformal radiation therapy for non-small cell lung cancer. (1997) (207)
- The IASLC Lung Cancer Staging Project: External Validation of the Revision of the TNM Stage Groupings in the Eighth Edition of the TNM Classification of Lung Cancer (2017) (203)
- Prognostic Factors in the Treatment of Malignant Pleural Mesothelioma at a Large Tertiary Referral Center (2007) (200)
- The IASLC Lung Cancer Staging Project: Background Data and Proposed Criteria to Distinguish Separate Primary Lung Cancers from Metastatic Foci in Patients with Two Lung Tumors in the Forthcoming Eighth Edition of the TNM Classification for Lung Cancer (2016) (197)
- Comprehensive Histologic Assessment Helps to Differentiate Multiple Lung Primary Nonsmall Cell Carcinomas From Metastases (2009) (194)
- The importance of surgical staging in the treatment of malignant pleural mesothelioma. (1996) (194)
- Pulmonary metastasectomy. Current indications. (1995) (193)
- High telomerase activity in primary lung cancers: association with increased cell proliferation rates and advanced pathologic stage. (1997) (192)
- Evidence against a role for SV40 infection in human mesotheliomas and high risk of false-positive PCR results owing to presence of SV40 sequences in common laboratory plasmids (2004) (192)
- Positron emission tomography defines metastatic disease but not locoregional disease in patients with malignant pleural mesothelioma. (2003) (192)
- Malignant esophagorespiratory fistula: management options and survival. (1991) (191)
- Surgical resection of stage IIIA and stage IIIB non-small-cell lung cancer after concurrent induction chemoradiotherapy. A Southwest Oncology Group trial. (1993) (191)
- Results of a phase I dose‐escalation study using three‐dimensional conformal radiotherapy in the treatment of inoperable nonsmall cell lung carcinoma (2005) (188)
- Prognostic Significance of Adenocarcinoma In Situ, Minimally Invasive Adenocarcinoma, and Nonmucinous Lepidic Predominant Invasive Adenocarcinoma of the Lung in Patients With Stage I Disease (2014) (188)
- EGFR mutations in lung adenocarcinomas: clinical testing experience and relationship to EGFR gene copy number and immunohistochemical expression. (2008) (185)
- A multi-institutional study confirms the presence and expression of simian virus 40 in human malignant mesotheliomas. (1998) (183)
- Pathologic diagnosis of advanced lung cancer based on small biopsies and cytology: a paradigm shift. (2010) (183)
- Identification of KIF5B-RET and GOPC-ROS1 Fusions in Lung Adenocarcinomas through a Comprehensive mRNA-Based Screen for Tyrosine Kinase Fusions (2012) (179)
- Prognostic factors for recurrence after pulmonary resection of colorectal cancer metastases. (2009) (178)
- Survival after resection of stage II non-small cell lung cancer. (1992) (178)
- Prevention of cancer in the next millennium: Report of the Chemoprevention Working Group to the American Association for Cancer Research. (1999) (178)
- A phase II trial of pleurectomy/decortication followed by intrapleural and systemic chemotherapy for malignant pleural mesothelioma. (1994) (177)
- Influence of surgical resection and brachytherapy in the management of superior sulcus tumor. (1994) (176)
- American Joint Committee on Cancer staging system does not accurately predict survival in patients receiving multimodality therapy for esophageal adenocarcinoma. (2007) (176)
- An initial experience with FDG-PET in the imaging of residual disease after induction therapy for lung cancer. (2002) (176)
- Incidence and risk factors for lung injury after lung cancer resection. (2007) (175)
- Clinical impact of immune microenvironment in stage I lung adenocarcinoma: tumor interleukin-12 receptor β2 (IL-12Rβ2), IL-7R, and stromal FoxP3/CD3 ratio are independent predictors of recurrence. (2013) (175)
- A proposed new international TNM staging system for malignant pleural mesothelioma from the International Mesothelioma Interest Group. (1996) (171)
- Comprehensive Genomic Analysis Reveals Clinically Relevant Molecular Distinctions between Thymic Carcinomas and Thymomas (2009) (162)
- Prevalence and mortality of acute lung injury and ARDS after lung resection. (2006) (160)
- Distinct Clinical Course of EGFR-Mutant Resected Lung Cancers: Results of Testing of 1118 Surgical Specimens and Effects of Adjuvant Gefitinib and Erlotinib (2012) (160)
- Surgical implications of the new IASLC/ATS/ERS adenocarcinoma classification (2011) (159)
- Aberrant expression of p53 or the epidermal growth factor receptor is frequent in early bronchial neoplasia and coexpression precedes squamous cell carcinoma development. (1995) (159)
- Induction Chemotherapy, Extrapleural Pneumonectomy, and Postoperative High-Dose Radiotherapy for Locally Advanced Malignant Pleural Mesothelioma: A Phase II Trial (2006) (158)
- Malignant mesothelioma in Australia (2006) (156)
- Long-term results of combined-modality therapy in resectable non-small-cell lung cancer. (2002) (155)
- Initial results of pulmonary resection after neoadjuvant nivolumab in patients with resectable non-small cell lung cancer. (2019) (154)
- Differential proliferation of fibroblasts cultured from normal and fibrotic human lungs. (1988) (153)
- The IASLC Lung Cancer Staging Project: Summary of Proposals for Revisions of the Classification of Lung Cancers with Multiple Pulmonary Sites of Involvement in the Forthcoming Eighth Edition of the TNM Classification (2016) (152)
- Clinical pattern and pathologic stage but not histologic features predict outcome for bronchioloalveolar carcinoma. (2002) (152)
- Impact of Increasing Age on Cause-Specific Mortality and Morbidity in Patients With Stage I Non-Small-Cell Lung Cancer: A Competing Risks Analysis. (2017) (151)
- Thymic carcinoma: current staging does not predict prognosis. (1998) (151)
- The clamshell incision: an improved approach to bilateral pulmonary and mediastinal tumor. (1994) (149)
- Mesothelin Overexpression Promotes Mesothelioma Cell Invasion and MMP-9 Secretion in an Orthotopic Mouse Model and in Epithelioid Pleural Mesothelioma Patients (2012) (149)
- Prognostic Immune Markers in Non–Small Cell Lung Cancer (2011) (149)
- Factors determining outcome after surgical resection of T3 and T4 lung cancers of the superior sulcus. (2000) (146)
- Hemithoracic radiation therapy after pleurectomy/decortication for malignant pleural mesothelioma. (2005) (146)
- Prediction rule for atrial fibrillation after major noncardiac thoracic surgery. (2005) (145)
- The IASLC Mesothelioma Staging Project: Proposals for the M Descriptors and for Revision of the TNM Stage Groupings in the Forthcoming (Eighth) Edition of the TNM Classification for Mesothelioma (2016) (142)
- The utility of positron emission tomography in staging of potentially operable carcinoma of the thoracic esophagus: results of the American College of Surgeons Oncology Group Z0060 trial. (2007) (141)
- Primary sarcomas of the mediastinum: results of therapy. (1998) (140)
- Extent of chest wall invasion and survival in patients with lung cancer. (1999) (140)
- Hemithoracic radiation after extrapleural pneumonectomy for malignant pleural mesothelioma. (2003) (139)
- Gene expression profiling allows distinction between primary and metastatic squamous cell carcinomas in the lung. (2005) (139)
- Effects of diltiazem prophylaxis on the incidence and clinical outcome of atrial arrhythmias after thoracic surgery. (2000) (139)
- Pleural intensity-modulated radiotherapy for malignant pleural mesothelioma. (2012) (138)
- Positron emission tomography predicts survival in malignant pleural mesothelioma. (2006) (138)
- The role of surgical cytoreduction in the treatment of malignant pleural mesothelioma: meeting summary of the International Mesothelioma Interest Group Congress, September 11-14, 2012, Boston, Mass. (2013) (137)
- Genomic and Mutational Profiling to Assess Clonal Relationships Between Multiple Non–Small Cell Lung Cancers (2009) (137)
- A nuclear grading system is a strong predictor of survival in epitheloid diffuse malignant pleural mesothelioma (2012) (135)
- p53 immunostaining positivity is associated with reduced survival and is imperfectly correlated with gene mutations in resected non-small cell lung cancer. A preliminary report of LCSG 871. (1994) (134)
- Phase II Study of Hemithoracic Intensity-Modulated Pleural Radiation Therapy (IMPRINT) As Part of Lung-Sparing Multimodality Therapy in Patients With Malignant Pleural Mesothelioma. (2016) (132)
- The use of CDKN2A deletion as a diagnostic marker for malignant mesothelioma in body cavity effusions (2002) (132)
- Video-assisted thoracic surgery does not reduce the incidence of postoperative atrial fibrillation after pulmonary lobectomy. (2007) (131)
- Overexpression of cyclins D1 and E is frequent in bronchial preneoplasia and precedes squamous cell carcinoma development. (1999) (129)
- Esophageal Cancer Recurrence Patterns and Implications for Surveillance (2013) (127)
- Associations Between Mutations and Histologic Patterns of Mucin in Lung Adenocarcinoma: Invasive Mucinous Pattern and Extracellular Mucin Are Associated With KRAS Mutation (2014) (126)
- Molecular markers help characterize neuroendocrine lung tumors. (1996) (126)
- Neoadjuvant atezolizumab in resectable non-small cell lung cancer (NSCLC): Interim analysis and biomarker data from a multicenter study (LCMC3). (2019) (125)
- SELECT: A Phase II Trial of Adjuvant Erlotinib in Patients With Resected Epidermal Growth Factor Receptor-Mutant Non-Small-Cell Lung Cancer. (2019) (124)
- Lobectomy improves ventilatory function in selected patients with severe COPD. (1998) (124)
- A grading system combining architectural features and mitotic count predicts recurrence in stage I lung adenocarcinoma (2012) (124)
- Pulmonary Metastasectomy for Head and Neck Cancers (1999) (123)
- Worldwide Esophageal Cancer Collaboration: clinical staging data. (2016) (122)
- Intrapleural cisplatin and cytarabine in the management of malignant pleural effusions: a Lung Cancer Study Group trial. (1991) (122)
- Video-assisted thoracoscopic surgery (VATS) lobectomy: catastrophic intraoperative complications. (2011) (121)
- Preoperative 18[F]-fluorodeoxyglucose positron emission tomography standardized uptake values predict survival after esophageal adenocarcinoma resection. (2006) (117)
- Core needle lung biopsy specimens: adequacy for EGFR and KRAS mutational analysis. (2010) (117)
- The cribriform pattern identifies a subset of acinar predominant tumors with poor prognosis in patients with stage I lung adenocarcinoma: a conceptual proposal to classify cribriform predominant tumors as a distinct histologic subtype (2014) (117)
- Predictors of survival in malignant tumors of the sternum. (1996) (115)
- Comparison of patterns of relapse in thymic carcinoma and thymoma. (2008) (115)
- The MARS feasibility trial: conclusions not supported by data. (2011) (114)
- Accuracy of lung imaging in metastases with implications for the role of thoracoscopy. (1993) (114)
- Predictors of Outcomes after Surgical Treatment of Synchronous Primary Lung Cancers (2007) (114)
- Mesothelin Overexpression Is a Marker of Tumor Aggressiveness and Is Associated with Reduced Recurrence-Free and Overall Survival in Early-Stage Lung Adenocarcinoma (2013) (114)
- The IASLC Mesothelioma Staging Project: Proposals for Revisions of the T Descriptors in the Forthcoming Eighth Edition of the TNM Classification for Pleural Mesothelioma (2016) (112)
- The IASLC Mesothelioma Staging Project: Proposals for Revisions of the N Descriptors in the Forthcoming Eighth Edition of the TNM Classification for Pleural Mesothelioma (2016) (112)
- Effects of diltiazem versus digoxin on dysrhythmias and cardiac function after pneumonectomy. (1997) (111)
- Intrapleural cisplatin and mitomycin for malignant mesothelioma following pleurectomy: pharmacokinetic studies. (1992) (111)
- Primary bony and cartilaginous sarcomas of chest wall: results of therapy. (1992) (110)
- Fludeoxyglucose positron emission tomography in the diagnosis of giant cell arteritis. (2001) (109)
- Pleomorphic Epithelioid Diffuse Malignant Pleural Mesothelioma: A Clinicopathological Review and Conceptual Proposal to Reclassify as Biphasic or Sarcomatoid Mesothelioma (2011) (109)
- Current Status and Future Perspectives on Neoadjuvant Therapy in Lung Cancer (2018) (109)
- Cyclin D1 proteolysis: a retinoid chemoprevention signal in normal, immortalized, and transformed human bronchial epithelial cells. (1999) (108)
- The IASLC Lung Cancer Staging Project: Data Elements for the Prospective Project (2009) (108)
- Using frozen section to identify histological patterns in stage I lung adenocarcinoma of ≤3 cm: accuracy and interobserver agreement (2015) (107)
- Treatment and prognosis in bronchial carcinoids involving regional lymph nodes. (1994) (107)
- Casein Kinase II Alpha Subunit and C1-Inhibitor Are Independent Predictors of Outcome in Patients with Squamous Cell Carcinoma of the Lung (2004) (106)
- The new IASLC/ATS/ERS international multidisciplinary lung adenocarcinoma classification (2009) (104)
- The epidermal growth factor receptor and its ligands as therapeutic targets in human tumors. (1996) (104)
- A phase I trial of regional mesothelin-targeted CAR T-cell therapy in patients with malignant pleural disease, in combination with the anti-PD-1 agent pembrolizumab. (2021) (102)
- Phase I trial of escalating-dose irinotecan given weekly with cisplatin and concurrent radiotherapy in locally advanced esophageal cancer. (2003) (100)
- A phase II trial of chemotherapy and surgery for non-small cell lung cancer patients with a synchronous solitary metastasis. (2002) (100)
- Thoracic Epithelioid Malignant Vascular Tumors: A Clinicopathologic Study of 52 Cases With Emphasis on Pathologic Grading and Molecular Studies of WWTR1-CAMTA1 Fusions (2015) (99)
- Small-cell carcinoma of the esophagus and gastroesophageal junction: review of the Memorial Sloan-Kettering experience. (2008) (99)
- EURACAN/IASLC proposals for updating the histologic classification of pleural mesothelioma: towards a more multidisciplinary approach. (2020) (97)
- Neoadjuvant and adjuvant chemotherapy in resected pulmonary large cell neuroendocrine carcinomas: a single institution experience. (2011) (97)
- Comprehensive Pathological Analyses in Lung Squamous Cell Carcinoma: Single Cell Invasion, Nuclear Diameter, and Tumor Budding Are Independent Prognostic Factors for Worse Outcomes (2014) (94)
- Inhibited transformation of immortalized human bronchial epithelial cells by retinoic acid is linked to cyclin E down-regulation. (1996) (94)
- Post-treatment Endoscopic Biopsy Is a Poor-Predictor of Pathologic Response in Patients Undergoing Chemoradiation Therapy for Esophageal Cancer (2009) (91)
- Mortality increases for octogenarians undergoing esophagogastrectomy for esophageal cancer. (2006) (91)
- COVID-19 guidance for triage of operations for thoracic malignancies: A consensus statement from Thoracic Surgery Outcomes Research Network (2020) (91)
- The role of computed tomography scanning in the initial assessment and the follow-up of malignant pleural mesothelioma. (1988) (91)
- A prospective trial comparing pain and quality of life measures after anatomic lung resection using thoracoscopy or thoracotomy. (2014) (91)
- Palliation and Pleurodesis in Malignant Pleural Effusion: The Role for Tunneled Pleural Catheters (2011) (90)
- Management of non-small cell lung cancer with direct mediastinal involvement. (1994) (90)
- A Prospective Study of Circulating Tumor DNA to Guide Matched Targeted Therapy in Lung Cancers. (2018) (89)
- Phase II Trial of Neoadjuvant Bevacizumab Plus Chemotherapy and Adjuvant Bevacizumab in Patients with Resectable Nonsquamous Non–Small-Cell Lung Cancers (2013) (88)
- Thoracoscopy under regional anesthesia for the diagnosis and management of pleural disease. (1987) (88)
- Pulmonary metastasectomy with therapeutic intent for soft‐tissue sarcoma (2017) (87)
- FDG-PET SUVmax Combined with IASLC/ATS/ERS Histologic Classification Improves the Prognostic Stratification of Patients with Stage I Lung Adenocarcinoma (2012) (87)
- Factors influencing ten-year survival in resected stages I to IIIa non-small cell lung cancer. (1999) (86)
- Mutational Analysis of EGFR and Related Signaling Pathway Genes in Lung Adenocarcinomas Identifies a Novel Somatic Kinase Domain Mutation in FGFR4 (2007) (85)
- Pulmonary metastasectomy for testicular germ cell tumors: a 28-year experience. (1998) (85)
- Predictive Value of Initial PET-SUVmax in Patients with Locally Advanced Esophageal and Gastroesophageal Junction Adenocarcinoma (2009) (84)
- Pleurectomy/decortication in the setting of multimodality treatment for diffuse malignant pleural mesothelioma. (1997) (84)
- Prospective evaluation of unilateral adrenal masses in patients with operable non-small-cell lung cancer. Impact of magnetic resonance imaging. (1994) (84)
- Proceedings of the IASLC International Workshop on Advances in Pulmonary Neuroendocrine Tumors 2007 (2008) (84)
- Combined thoracoscopic and laparoscopic robotic-assisted minimally invasive esophagectomy using a four-arm platform: experience, technique and cautions during early procedure development. (2013) (82)
- The IASLC Lung Cancer Staging Project: Background Data and Proposals for the Classification of Lung Cancer with Separate Tumor Nodules in the Forthcoming Eighth Edition of the TNM Classification for Lung Cancer (2016) (81)
- Pleurectomy/decortication and adjuvant therapy for malignant mesothelioma. (1993) (81)
- The management of high grade dysplasia and early cancer in Barrett's esophagus (1994) (78)
- Feasibility of multimodality therapy including extended resections in stage IVA thymoma. (2007) (78)
- Clinical Characteristics of Patients with Malignant Pleural Mesothelioma Harboring Somatic BAP1 Mutations (2012) (78)
- Assessment of Therapy Responses and Prediction of Survival in Malignant Pleural Mesothelioma Through Computer-Aided Volumetric Measurement on Computed Tomography Scans (2010) (77)
- Neoadjuvant therapy: a novel and effective treatment for stage IIIb non-small cell lung cancer. Southwest Oncology Group. (1994) (77)
- Management of Pancoast tumours. (2006) (77)
- Acute subdural hematoma--an unusual sequela to lumbar puncture. (1979) (76)
- Frequency of EGFR and KRAS Mutations in Lung Adenocarcinomas in African Americans (2011) (75)
- A phase II trial of preoperative combined-modality therapy for localized esophageal carcinoma: initial results. (2002) (74)
- Detection and measurement of occult disease for the prognosis of solid tumors. (2003) (74)
- Chronic inflammation in tumor stroma is an independent predictor of prolonged survival in epithelioid malignant pleural mesothelioma patients (2011) (74)
- COVID-19 Guidance for Triage of Operations for Thoracic Malignancies: A Consensus Statement From Thoracic Surgery Outcomes Research Network (2020) (73)
- Lymph node mapping of esophageal cancer. (1994) (72)
- Safety and Feasibility of Lung Resection After Immunotherapy for Metastatic or Unresectable Tumors. (2018) (72)
- Lymphadenectomy for Adenocarcinoma of the Gastroesophageal Junction (GEJ): Impact of Adequate Staging on Outcome (2007) (72)
- The impact of lymph node station on survival in 348 patients with surgically resected malignant pleural mesothelioma: implications for revision of the American Joint Committee on Cancer staging system. (2008) (71)
- Medical tumors of the chest wall. Solitary plasmacytoma and Ewing's sarcoma. (1993) (71)
- Current and Future Management of Malignant Mesothelioma: A Consensus Report from the National Cancer Institute Thoracic Malignancy Steering Committee, International Association for the Study of Lung Cancer, and Mesothelioma Applied Research Foundation (2018) (71)
- Chest wall resection for locally recurrent breast cancer: is it worthwhile? (2000) (71)
- Regional delivery of mesothelin-targeted CAR T cells for pleural cancers: Safety and preliminary efficacy in combination with anti-PD-1 agent. (2019) (70)
- Use of epidermal growth factor receptor/Kirsten rat sarcoma 2 viral oncogene homolog mutation testing to define clonal relationships among multiple lung adenocarcinomas: comparison with clinical guidelines. (2010) (69)
- Surgical treatment of superior sulcus tumors with spinal and brachial plexus involvement. (2002) (68)
- Phase 2 trial of induction and concurrent chemoradiotherapy with weekly irinotecan and cisplatin followed by surgery for esophageal cancer (2012) (67)
- Worldwide Esophageal Cancer Collaboration: pathologic staging data. (2016) (67)
- Surgical management of thoracic malignancies invading the heart or great vessels. (2004) (67)
- Novel oncolytic agent GLV-1h68 is effective against malignant pleural mesothelioma. (2008) (65)
- Management of major hemorrhage during mediastinoscopy. (2003) (64)
- Cisplatin-induced GADD34 upregulation potentiates oncolytic viral therapy in the treatment of malignant pleural mesothelioma (2006) (63)
- Occult metastases in lymph nodes predict survival in resectable non-small-cell lung cancer: report of the ACOSOG Z0040 trial. (2011) (62)
- Thirty-day mortality underestimates the risk of early death after major resections for thoracic malignancies. (2014) (62)
- Recurrence of pulmonary carcinoid tumors after resection: implications for postoperative surveillance. (2013) (62)
- Endoscopic ultrasound predicts outcomes for patients with adenocarcinoma of the gastroesophageal junction. (2007) (61)
- Worldwide Esophageal Cancer Collaboration: neoadjuvant pathologic staging data. (2016) (61)
- A cancer staging primer: esophagus and esophagogastric junction. (2010) (61)
- Brain natriuretic peptide and risk of atrial fibrillation after thoracic surgery. (2012) (61)
- Attaining Proficiency in Robotic-Assisted Minimally Invasive Esophagectomy While Maximizing Safety during Procedure Development (2016) (60)
- The seventh edition of the American Joint Committee on Cancer/International Union Against Cancer Staging Manuals: the new era of data-driven revisions. (2010) (60)
- DNA damage and repair capacity in patients with lung cancer: prediction of multiple primary tumors. (2008) (60)
- Supplementary Prognostic Variables for Pleural Mesothelioma (2014) (60)
- New Insights on Diagnostic Reproducibility of Biphasic Mesotheliomas: A Multi‐Institutional Evaluation by the International Mesothelioma Panel From the MESOPATH Reference Center (2018) (58)
- Patterns of recurrence and incidence of second primary tumors after lobectomy by means of video-assisted thoracoscopic surgery (VATS) versus thoracotomy for lung cancer. (2011) (58)
- Imaging and therapy of malignant pleural mesothelioma using replication‐competent herpes simplex viruses (2006) (57)
- Fluorine-18 fluorodeoxyglucose positron emission tomographic maximal standardized uptake value predicts survival independent of clinical but not pathologic TNM staging of resected non-small cell lung cancer. (2007) (57)
- A Multicenter Study of Volumetric Computed Tomography for Staging Malignant Pleural Mesothelioma. (2016) (57)
- Initial Experience With Lung Cancer Resection After Treatment With T-Cell Checkpoint Inhibitors. (2017) (57)
- Phase II study of the GI-4000 KRAS vaccine after curative therapy in patients with stage I-III lung adenocarcinoma harboring a KRAS G12C, G12D, or G12V mutation. (2014) (56)
- Differences in patterns of recurrence in early-stage versus locally advanced non-small cell lung cancer. (2014) (56)
- The epidemiology of traumatic rupture of the thoracic aorta in children: a 13-year review. (1990) (56)
- Molecular Characteristics Predict Clinical Outcomes: Prospective Trial Correlating Response to the EGFR Tyrosine Kinase Inhibitor Gefitinib with the Presence of Sensitizing Mutations in the Tyrosine Binding Domain of the EGFR Gene (2011) (56)
- Treatment of traumatic rupture of the thoracic aorta. A 15-year experience. (1990) (56)
- A Prediction Model for Pathologic N2 Disease in Lung Cancer Patients with a Negative Mediastinum by Positron Emission Tomography (2013) (55)
- Esophageal Cancer: Associations With (pN+) Lymph Node Metastases. (2016) (55)
- Intraoperative Near-Infrared Fluorescence Imaging as an Adjunct to Robotic-Assisted Minimally Invasive Esophagectomy (2014) (53)
- The IASLC Mesothelioma Staging Project: Improving Staging of a Rare Disease Through International Participation (2016) (53)
- Randomized controlled trial of a special acupuncture technique for pain after thoracotomy. (2008) (53)
- Esophageal Cancer: Associations With (pN+) Lymph Node Metastases (2017) (53)
- Radiation therapy potentiates effective oncolytic viral therapy in the treatment of lung cancer. (2005) (52)
- Contemporary Analysis of Prognostic Factors in Patients with Unresectable Malignant Pleural Mesothelioma (2016) (52)
- The nuclear deubiquitinase BAP 1 is commonly inactivated by somatic mutations and 3 p 21 . 1 losses in malignant pleural mesothelioma (2015) (52)
- Coactivation of Receptor Tyrosine Kinases in Malignant Mesothelioma as a Rationale for Combination Targeted Therapy (2011) (52)
- Expression profiling and identification of potential molecular targets for therapy in pulmonary large-cell neuroendocrine carcinoma. (2011) (52)
- Vocal cord medialization for unilateral paralysis associated with intrathoracic malignancies. (1996) (51)
- Failure patterns after hemithoracic pleural intensity modulated radiation therapy for malignant pleural mesothelioma. (2014) (51)
- Early Quality of Life Outcomes After Robotic-Assisted Minimally Invasive and Open Esophagectomy. (2019) (50)
- Neoadjuvant atezolizumab in resectable non-small cell lung cancer (NSCLC): Initial results from a multicenter study (LCMC3). (2018) (50)
- Real‐time diagnostic imaging of tumors and metastases by use of a replication‐competent herpes vector to facilitate minimally invasive oncological surgery (2006) (50)
- Intrapleural chemotherapy without pleurodesis for malignant pleural effusions. LCSG Trial 861. (1994) (49)
- Contemporary Results of Surgical Resection of Non-small Cell Lung Cancer After Induction Therapy: A Review of 549 Consecutive Cases (2011) (49)
- PS01.05 Surgical and Clinical Outcomes With Neoadjuvant Atezolizumab in Resectable Stage IB–IIIB NSCLC: LCMC3 Trial Primary Analysis (2021) (49)
- Comprehensive Next-Generation Sequencing Unambiguously Distinguishes Separate Primary Lung Carcinomas From Intrapulmonary Metastases: Comparison with Standard Histopathologic Approach (2019) (48)
- Morphologic features of adenocarcinoma of the lung predictive of response to the epidermal growth factor receptor kinase inhibitors erlotinib and gefitinib. (2009) (47)
- The Use of Radiation Therapy for the Treatment of Malignant Pleural Mesothelioma: Expert Opinion from the National Cancer Institute Thoracic Malignancy Steering Committee, International Association for the Study of Lung Cancer, and Mesothelioma Applied Research Foundation. (2019) (47)
- Improved Outcomes with Modern Lung‐Sparing Trimodality Therapy in Patients with Malignant Pleural Mesothelioma (2017) (47)
- Pericardial effusions in the cancer population: prognostic factors after pericardial window and the impact of paradoxical hemodynamic instability. (2011) (47)
- Insulin-Like Growth Factor-1 Receptor Expression in Thymic Malignancies (2010) (47)
- Use of the argon beam electrocoagulator for performing pulmonary wedge resections. (1990) (47)
- The clinical course of lung carcinoma in patients with chronic lymphocytic leukemia (1999) (47)
- Cost-effectiveness of pulmonary resection and systemic chemotherapy in the management of metastatic soft tissue sarcoma: a combined analysis from the University of Texas M. D. Anderson and Memorial Sloan-Kettering Cancer Centers. (2004) (45)
- Radiation-Induced Cellular DNA Damage Repair Response Enhances Viral Gene Therapy Efficacy in the Treatment of Malignant Pleural Mesothelioma (2006) (45)
- Thyroid transcription factor‐1 expression is an independent predictor of recurrence and correlates with the IASLC/ATS/ERS histologic classification in patients with stage I lung adenocarcinoma (2013) (44)
- Do we need a revised staging system for malignant pleural mesothelioma? Analysis of the IASLC database. (2012) (44)
- A flow cytometric study of non‐small cell lung cancer classified as T1N0 (1992) (43)
- The proposed new international TNM staging system for malignant pleural mesothelioma: application to imaging. (1996) (43)
- Are cancers of the esophagus, gastroesophageal junction, and cardia one disease, two, or several? (2004) (43)
- Patterns of Local and Nodal Failure in Malignant Pleural Mesothelioma After Extrapleural Pneumonectomy and Photon-Electron Radiotherapy (2009) (42)
- Resection of Primary Mediastinal Non-Seminomatous Germ Cell Tumors: A 28-Year Experience at Memorial Sloan-Kettering Cancer Center (2011) (42)
- Management and outcomes of relapse after treatment for thymoma and thymic carcinoma. (2011) (41)
- Tracheal schwannoma: management by endoscopic laser resection. (1994) (41)
- Reflex testing of resected stage I through III lung adenocarcinomas for EGFR and KRAS mutation: report on initial experience and clinical utility at a single center. (2011) (41)
- The replication-competent oncolytic herpes simplex mutant virus NV1066 is effective in the treatment of esophageal cancer. (2003) (40)
- Clinicopathological features and the impact of the new TNM classification of malignant tumors in patients with pulmonary large cell neuroendocrine carcinoma. (2013) (40)
- Tension pneumocephalus resulting from iatrogenic subarachnoid-pleural fistulae: report of three cases. (2001) (40)
- A Randomized Phase II Trial of Adjuvant Galinpepimut-S, WT-1 Analogue Peptide Vaccine, After Multimodality Therapy for Patients with Malignant Pleural Mesothelioma (2017) (40)
- Minimally invasive localization of oncolytic herpes simplex viral therapy of metastatic pleural cancer (2006) (39)
- Pemetrexed and cisplatin for malignant pleural mesothelioma: a new standard of care? (2003) (39)
- Second primary lung cancers: smokers versus nonsmokers after resection of stage I lung adenocarcinoma. (2014) (39)
- North American Multicenter Volumetric CT Study for Clinical Staging of Malignant Pleural Mesothelioma: Feasibility and Logistics of Setting Up a Quantitative Imaging Study (2016) (39)
- Mediastinoscopy: an endangered species? (2005) (38)
- VATS Port Site Recurrence: A Technique Dependent Problem (2001) (38)
- Adaptive Neoadjuvant Chemotherapy Guided by 18F‐FDG PET in Resectable Non–Small Cell Lung Cancers: The NEOSCAN Trial (2016) (38)
- Surgery for bronchioloalveolar carcinoma and "very early" adenocarcinoma: an evolving standard of care? (2006) (38)
- Free flap chest wall reconstruction for recurrent breast cancer and radiation ulcers. (1993) (38)
- The IASLC Lung Cancer Staging Project: A Renewed Call to Participation. (2018) (37)
- Tissue and Serum Mesothelin Are Potential Markers of Neoplastic Progression in Barrett's Associated Esophageal Adenocarcinoma (2012) (37)
- Airway spray cryotherapy: initial outcomes from a multiinstitutional registry. (2012) (37)
- Recurrence patterns after resection of soft tissue sarcomas of the chest wall. (2013) (37)
- Postoperative fluorescence bronchoscopic surveillance in non-small cell lung cancer patients. (2001) (36)
- Neoadjuvant nivolumab in early-stage, resectable non-small cell lung cancers. (2017) (36)
- Resection of lung cancer invading the diaphragm. (1997) (35)
- Preoperative Consolidation-to-Tumor Ratio and SUVmax Stratify the Risk of Recurrence in Patients Undergoing Limited Resection for Lung Adenocarcinoma ≤2 cm (2013) (34)
- The performance of four pleural drainage systems in an animal model of bronchopleural fistula. (1988) (33)
- Visceral pleural invasion does not affect recurrence or overall survival among patients with lung adenocarcinoma ≤ 2 cm: a proposal to reclassify T1 lung adenocarcinoma. (2013) (32)
- SCCRO (DCUN1D1) Induces Extracellular Matrix Invasion by Activating Matrix Metalloproteinase 2 (2008) (32)
- Comprehensive molecular and pathological evaluation of transitional mesothelioma assisted by deep learning approach: a multi institutional study of the International Mesothelioma Panel from MESOPATH Reference Center. (2020) (32)
- A Prospective Study of Tumor Suppressor Gene Methylation as a Prognostic Biomarker in Surgically Resected Stage I to IIIA Non–Small-Cell Lung Cancers (2014) (32)
- Indications for pneumonectomy. Extrapleural pneumonectomy. (1999) (32)
- Prognostic Factors After Combined Modality Treatment of Squamous Cell Carcinoma of the Esophagus (2007) (31)
- Utility of Routine PET Imaging to Predict Response and Survival After Induction Therapy for Non-Small Cell Lung Cancer. (2016) (31)
- Flow cytometric analysis of malignant pleural mesotheliomas. (1989) (31)
- Soluble mesothelin related peptides (SMRP) and osteopontin as protein biomarkers for malignant mesothelioma: analytical validation of ELISA based assays and characterization at mRNA and protein levels (2010) (31)
- Abstract CT036: A phase I clinical trial of malignant pleural disease treated with regionally delivered autologous mesothelin-targeted CAR T cells: Safety and efficacy (2019) (31)
- Intraoperative localization of lymph node metastases with a replication-competent herpes simplex virus. (2006) (31)
- High SUVmax on FDG-PET Indicates Pleomorphic Subtype in Epithelioid Malignant Pleural Mesothelioma: Supportive Evidence to Reclassify Pleomorphic as Nonepithelioid Histology (2012) (30)
- Replication-competent herpes virus NV1020 as direct treatment of pleural cancer in a rat model. (2002) (30)
- Clinical tools do not predict pathological complete response in patients with esophageal squamous cell cancer treated with definitive chemoradiotherapy. (2014) (30)
- Trimodality therapy for superior sulcus non-small cell lung cancer: Southwest Oncology Group-Intergroup Trial S0220. (2014) (29)
- Acupuncture is a feasible treatment for post-thoracotomy pain: results of a prospective pilot trial (2006) (29)
- Cancer antigen profiling for malignant pleural mesothelioma immunotherapy: expression and coexpression of mesothelin, cancer antigen 125, and Wilms tumor 1 (2017) (27)
- Pretreatment Dysphagia in Esophageal Cancer Patients May Eliminate the Need for Staging by Endoscopic Ultrasonography. (2016) (27)
- Adjuvant and neoadjuvant therapy for stages I through III non-small cell lung cancer. (1994) (27)
- Diagnosis and treatment of pleural mesothelioma. (1990) (27)
- Change in chemotherapy during concurrent radiation followed by surgery after a suboptimal positron emission tomography response to induction chemotherapy improves outcomes for locally advanced esophageal adenocarcinoma (2016) (27)
- Neoadjuvant therapy for lung cancer: a note of caution. (1993) (26)
- Growth suppression of transformed human bronchial epithelial cells by all-trans-retinoic acid occurs through specific retinoid receptors. (1995) (26)
- The clinical course of nonsmall cell lung carcinoma in survivors of Hodgkin disease (2002) (25)
- Results of a phase I dose escalation study in the treatment of inoperable non-small cell lung cancer (2003) (25)
- Perioperative blood transfusion has a dose-dependent relationship with disease recurrence and survival in patients with non-small cell lung cancer. (2019) (25)
- The role of prophylactic cranial irradiation in regionally advanced non-small cell lung cancer. A Southwest Oncology Group Study. (1989) (24)
- Patterns of symptoms following surgery for esophageal cancer. (2013) (24)
- Clinical features and current treatment of diffuse malignant pleural mesothelioma. (1995) (24)
- Surgical techniques for pulmonary metastasectomy. (2002) (24)
- Extrapleural pneumonectomy and extended pleurectomy/decortication for malignant pleural mesothelioma: the Memorial Sloan-Kettering Cancer Center approach. (2012) (24)
- Comprehensive Molecular and Clinicopathologic Analysis of 200 Pulmonary Invasive Mucinous Adenocarcinomas Identifies Distinct Characteristics of Molecular Subtypes (2021) (24)
- A pilot trial of high-dose-rate intraoperative radiation therapy for malignant pleural mesothelioma. (2005) (24)
- O-035 Phase III trial of concurrent chemotherapy and radiotherapy(CT/RT) vs CT/RT followed by surgical resection for stage IIIa(pN2)non-small cell lung cancer (NSCLC): Outcomes and implications for surgical management in North American Intergroup 0139 (RTOG 9309) (2005) (24)
- Massive pulmonary hemangiopericytoma. An innovative approach to evaluation and treatment (1989) (23)
- Hemithoracic radiotherapy for mesothelioma: lack of benefit or lack of statistical power? (2016) (23)
- Comprehensive long-term care of patients with lung cancer: development of a novel thoracic survivorship program. (2014) (23)
- Crohn's disease in the older patient. (1980) (22)
- Scalpels, beams, drugs, and dreams: challenges of stage IIIA-N2 non-small-cell lung cancer. (2007) (22)
- Role of induction therapy: surgical resection of non-small cell lung cancer after induction therapy. (2013) (22)
- Malignant mesothelioma from neighborhood exposure to anthophyllite asbestos. (2001) (22)
- Multiple high-grade bronchial dysplasia and squamous cell carcinoma: concordant and discordant mutations. (2001) (22)
- Anatomy of the pleura. (2011) (22)
- Laparoscopy: An important tool in the staging of malignant pleural mesothelioma (1996) (22)
- OA06.06 Clinical/Biomarker Data for Neoadjuvant Atezolizumab in Resectable Stage IB-IIIB NSCLC: Primary Analysis in the LCMC3 Study (2021) (21)
- Postinduction positron emission tomography assessment of N2 nodes is not associated with ypN2 disease or overall survival in stage IIIA non-small cell lung cancer. (2016) (21)
- NR-LU-10 monoclonal antibody scanning. A helpful new adjunct to computed tomography in evaluating non-small-cell lung cancer. (1993) (21)
- SCCRO expression correlates with invasive progression in bronchioloalveolar carcinoma. (2004) (21)
- Dataset for Reporting of Malignant Mesothelioma of the Pleura or Peritoneum: Recommendations From the International Collaboration on Cancer Reporting (ICCR). (2016) (21)
- Real-time intraoperative detection of tissue hypoxia in gastrointestinal surgery by wireless pulse oximetry (2011) (21)
- Yield of brain 18F-FDG PET in evaluating patients with potentially operable non-small cell lung cancer. (2006) (21)
- Analysis of Tumor Genomic Pathway Alterations Using Broad-Panel Next-Generation Sequencing in Surgically Resected Lung Adenocarcinoma (2019) (21)
- Outcomes after neoadjuvant or adjuvant chemotherapy for cT2‐4N0‐1 non–small cell lung cancer: A propensity‐matched analysis (2019) (21)
- A brain natriuretic peptide-based prediction model for atrial fibrillation after thoracic surgery: Development and internal validation. (2019) (20)
- Pulmonary metastasectomy: a moving target. (2010) (20)
- Neoadjuvant atezolizumab for resectable non-small cell lung cancer: an open-label, single-arm phase II trial (2022) (20)
- Squamous Cell Carcinoma Related Oncogene Regulates Angiogenesis through Vascular Endothelial Growth Factor-A (2004) (20)
- Clinical and in vivo evidence that EGFR S768I mutant lung adenocarcinomas are sensitive to erlotinib. (2014) (20)
- Mediastinoscopy: an obsolete procedure? (2011) (20)
- Eighth Edition Staging of Thoracic Malignancies: Implications for the Reporting Pathologist. (2018) (20)
- A multicenter U.S. trial of neoadjuvant pemetrexed plus cisplatin (PC) followed by extrapleural pneumonectomy (EPP) and hemithoracic radiation (RT) for stage I-III malignant pleural mesothelioma (MPM) (2007) (20)
- Long-term Survival Based on the Surgical Approach to Lobectomy For Clinical Stage I Nonsmall Cell Lung Cancer: Comparison of Robotic, Video-assisted Thoracic Surgery, and Thoracotomy Lobectomy. (2016) (20)
- The American College of Surgeons Responds to COVID-19 (2020) (19)
- Trials in malignant mesothelioma. LCSG 851 and 882. (1994) (19)
- The American College of Surgeons Responds to COVID-19 (2020) (19)
- The Mars trial: resolution of the surgical controversies in mesothelioma? (2009) (18)
- Experimental therapeutics with a new 10-deazaaminopterin in human mesothelioma: further improving efficacy through structural design, pharmacologic modulation at the level of MRP ATPases, and combined therapy with platinums. (2001) (18)
- Parapneumonic and post-traumatic pleural space infections. (1994) (18)
- The quality metric prolonged length of stay misses clinically important adverse events. (2012) (18)
- Multimodality therapy for locally advanced thymomas: state of the art or investigational therapy? (2008) (18)
- Resection of superior sulcus tumors (posterior approach). (2004) (18)
- Two-Year Quality of Life Outcomes After Robotic-Assisted Minimally Invasive and Open Esophagectomy. (2019) (18)
- Editorial: Lung reduction surgery: A true advance? (1996) (17)
- Fluorescence-Assisted Cytological Testing (FACT): Ex Vivo Viral Method for Enhancing Detection of Rare Cancer Cells in Body Fluids (2011) (17)
- Prospective trial with preoperative gefitinib to correlate lung cancer response with EGFR exon 19 and 21 mutations and to select patients for adjuvant therapy. (2006) (17)
- Early operative outcomes and learning curve of robotic assisted giant paraesophageal hernia repair (2017) (17)
- Beneficial effects of perioperative statins for major pulmonary resection. (2015) (17)
- Phase II trial of preoperative bevacizumab (Bev), irinotecan (I), cisplatin (C), and radiation (RT) in esophageal adenocarcinoma: Preliminary safety analysis. (2009) (16)
- Solitary plasmacytoma and Ewing's sarcoma (1993) (16)
- Initial results of LC-MAP: An institutional program to routinely profile tumor specimens for the presence of mutations in targetable pathways in all patients with lung adenocarcinoma. (2010) (16)
- An In Vivo Platform for Tumor Biomarker Assessment (2011) (16)
- Stage III Non-small Cell Lung Cancer (2016) (15)
- The use of a next-generation sequencing-derived machine-learning risk-prediction model (OncoCast-MPM) for malignant pleural mesothelioma: a retrospective study (2021) (15)
- Chylothorax and Recurrent Laryngeal Nerve Injury Associated with Robotic Video-Assisted Mediastinal Lymph Node Dissection (2015) (15)
- Should the esophageal cancer staging system be revised? (2003) (15)
- Contribution of videothoracoscopy to the management of the cancer patient (1994) (15)
- Overall survival with circulating tumor DNA-guided therapy in advanced non-small-cell lung cancer (2021) (15)
- Ras oncogene point mutation: an infrequent event in bronchioloalveolar cancer. (1992) (14)
- Virally-directed fluorescent imaging (VFI) can facilitate endoscopic staging (2006) (14)
- Liquid biopsy for ctDNA to revolutionize the care of patients with early stage lung cancers. (2017) (14)
- Neoadjuvant therapy and surgical resection for locally advanced non-small cell lung cancer. (2000) (13)
- Resection of Primary and Secondary Tumors of the Sternum: An Analysis of Prognostic Variables. (2015) (13)
- Natural history of incidental appendectomy in patients with Crohn's disease who required subsequent bowel resection. (1982) (13)
- Heart Dosimetry is Correlated With Risk of Radiation Pneumonitis After Lung-Sparing Hemithoracic Pleural Intensity Modulated Radiation Therapy for Malignant Pleural Mesothelioma. (2017) (13)
- MA04.09 Neoadjuvant Atezolizumab in Resectable Non-Small Cell Lung Cancer (NSCLC): Updated Results from a Multicenter Study (LCMC3) (2018) (12)
- Surgical techniques for nonseminomatous germ cell tumors metastatic to the lung. (2002) (12)
- Medical and surgical care of mesothelioma patients and their relatives carrying germline BAP1 mutations. (2022) (12)
- Prevalence of occult peribronchial N1 nodal metastasis in peripheral clinical N0 <2 cm NSCLC. (2020) (12)
- Phase I study of intra-pleural administration of GL-ONC1, an oncolytic vaccinia virus, in patients with malignant pleural effusion. (2015) (12)
- Colon Carcinoma Metastatic to the Trachea: Report of a Case and a Review of the Literature (1994) (12)
- PLEURAL EFFUSION: BENIGN AND MALIGNANT (2008) (11)
- Neoadjuvant therapy for stage III lung cancer. (1993) (11)
- Risk of hemoptysis in patients with resected squamous cell and other high-risk lung cancers treated with adjuvant bevacizumab (2013) (11)
- Positron‐Emission Tomography Scan–Directed Chemoradiation for Esophageal Squamous Cell Carcinoma: No Benefit for a Change in Chemotherapy in Positron‐Emission Tomography Nonresponders (2019) (11)
- Phase II trial of preoperative combined modality therapy for esophageal carcinoma: Induction cisplatin-irinotecan followed by concurrent cisplatin-irinotecan and radiotherapy (2005) (10)
- The American Board of Thoracic Surgery: update. (2012) (10)
- Extrapleural pneumonectomy in children. (2006) (10)
- KEYNOTE-024: Unlocking a pathway to lung cancer cure? (2017) (10)
- Prognostic factors following complete resection of non-superior sulcus lung cancer invading the chest wall. (2020) (10)
- Nodal staging in lung cancer: lymph node location or number? (2011) (10)
- MARS: a sense of perspective and an inconvenient truth. (2013) (10)
- The American Board of Thoracic Surgery: update. (2012) (10)
- Operative outcomes using bevacizumab, docetaxel, and cisplatin as induction therapy in patients with operable lung cancer. (2009) (10)
- A multicenter phase 2 trial of neo-adjuvant pemetrexed plus cisplatin (PC) followed by extrapleural pneumonectomy (EPP) and radiation (RT) for malignant pleural mesothelioma (MPM) (2005) (9)
- Final report of the 70.2 GY and 75.6 GY dose levels of a phase I dose escalation study using three dimensional conformal radiotherapy in the treatment of inoperable lung cancer (1998) (9)
- Randomized phase II study of adjuvant WT1 vaccine (SLS-001) for malignant pleural mesothelioma (MPM) after multimodality therapy. (2016) (9)
- Long-term, disease-specific outcomes of thymic malignancies presenting with de novo pleural metastasis. (2020) (9)
- Phase II trial of bevacizumab, irinotecan, cisplatin, and radiation as preoperative therapy in esophageal adenocarcinoma. (2012) (9)
- Management of Synchronous Extrathoracic Oligometastatic Non-Small Cell Lung Cancer (2021) (9)
- Epidermal growth factor receptor signaling in adenocarcinomas with bronchioloalveolar components. (2008) (9)
- Surgical management of malignant pleural mesothelioma. (2013) (8)
- Lung reduction surgery: a true advance? (1996) (8)
- The optimal treatment of malignant pleural effusions. A continuing dilemma. (1991) (8)
- Summary of current cooperative group clinical trials in thoracic malignancies. The Thoracic Intergroup. (1994) (8)
- Despite some expression of folate receptor alpha in human mesothelioma cells, internalization of methotrexate is predominantly carrier mediated. (2002) (8)
- Outcomes After Multidisciplinary Management of Primary Mediastinal Germ Cell Tumors (2020) (8)
- Casein Kinase II Alpha Subunit and C 1-Inhibitor Are Independent Predictors of Outcome in Patients with Squamous Cell Carcinoma of the Lung (2004) (8)
- OA13.07 Neoadjuvant Atezolizumab in Resectable NSCLC Patients: Immunophenotyping Results from the Interim Analysis of the Multicenter Trial LCMC3 (2019) (8)
- KRASG12C Mutation Is Associated with Increased Risk of Recurrence in Surgically Resected Lung Adenocarcinoma (2021) (8)
- Phase II study of bevacizumab and preoperative chemoradiation for esophageal adenocarcinoma. (2016) (8)
- Endodermal sinus tumor of the mediastinum. Report of apparent cure in two patients with extensive disease. (1984) (8)
- A prospective study to correlate EGFR mutations with gefitinib response (2005) (7)
- 2009 AJCC/UICC staging of esophageal cancer (2011) (7)
- Randomized, double-blinded, phase II trial of a WT1 peptide vaccine as adjuvant therapy in patients with malignant pleural mesothelioma (MPM). (2011) (7)
- Molecular biologic features of non-small cell lung cancer. Clinical implications. (1995) (7)
- Successful treatment of esophageal cancer with airway invasion with induction chemotherapy and concurrent chemoradiotherapy. (2009) (7)
- Phase II trial of preoperative cisplatin-irinotecan followed by concurrent cisplatin-irinotecan and radiotherapy: PET scan after induction therapy may identify early treatment failure. (2006) (7)
- The AJCC staging system does not predict survival in patients receiving multimodality therapy for esophageal cancer (2005) (7)
- O-268 Induction chemoradiotherapy and surgical resection for non-small cell lung carcinomas of the superior sulcus: Prediction and impact of pathologic complete response (CR) (2003) (7)
- EGFR mutations in men and cigarette smokers with lung adenocarcinoma. (2010) (7)
- Malignant Pleural Mesothelioma: Are There Imaging Characteristics Associated With Different Histologic Subtypes on Computed Tomography? (2018) (7)
- A Proposed System Toward Standardizing Surgery-based Treatments for Malignant Pleural Mesothelioma, From the Joint NCI-IASLC-MARF Taskforce. (2019) (7)
- Outcomes of induction chemotherapy followed by chemoradiation using intensity-modulated radiation therapy for esophageal adenocarcinoma. (2014) (7)
- Effect of furosemide on fully established low pressure pulmonary edema (1986) (6)
- External validation of surgical risk preoperative assessment system (SURPAS) in pulmonary resection. (2020) (6)
- Extra-anatomic Bypass for Aortic Sepsis: A Cautionary Note (1982) (6)
- The American College of Surgeons Surgical Risk Calculator performs well for pulmonary resection: A validation study. (2021) (6)
- Phase II study of induction and adjuvant bevacizumab in patients with stage IB-IIIA non-small cell lung cancer (NSCLC) receiving induction docetaxel and cisplatin. (2009) (6)
- Radiologic Considerations And Standardization Of Malignant Pleural Mesothelioma (MPM) Imaging Within Clinical Trials: Consensus Statement From The NCI Thoracic Malignancy Steering Committee - International Association For The Study Of Lung Cancer - Mesothelioma Applied Research Foundation Clinical T (2019) (6)
- Endoscopic spray cryotherapy for genitourinary malignancies: safety and efficacy in a porcine model (2013) (6)
- Has Reconstruction of the Central Airways Been Transformed?: From Aorta to Trachea. (2018) (6)
- Evidence-based outcomes for patients with non-small cell lung cancer undergoing resection. (2000) (6)
- Advanced lung cancer: aggressive surgical therapy vertebral body involvement. (2014) (6)
- Response: a critique of the international association for the study of lung cancer lymph node map. (2012) (5)
- Treatment of malignant pleural mesothelioma (1997) (5)
- LCMC LEADER neoadjuvant screening trial: LCMC4 evaluation of actionable drivers in early-stage lung cancers. (2022) (5)
- Induction chemotherapy, extrapleural pneumonectomy (EPP), and adjuvant hemithoracic radiation are feasible and effective for locally advanced malignant pleural mesothelioma (MPM) (2004) (5)
- Adjuvant therapy in non-small cell lung cancer. (2007) (5)
- The International Association for the Study of Lung Cancer (IASLC) Molecular Database Project: Objectives, Challenges and Opportunities. (2021) (5)
- Brief Report: Prevalence and Preliminary Validation of Screening Criteria to Identify Carriers of Germline BAP1 Mutations. (2019) (5)
- Modi fi cation of Pathologic T Classi fi cation for Non-small Cell Lung Cancer With Visceral Pleural Invasion Data From 1,055 Cases of Cancers # 3 cm (2021) (5)
- Prospective comparison of postoperative quality of life (QOL) in patients undergoing lobectomy by video-assisted thoracic surgery (VATS) versus thoracotomy for non-small cell lung cancer (NSCLC) (2008) (5)
- Neoadjuvant therapy : a novel and effective treatment for stage IIIb non-small cell lung cancer. Discussion (1994) (5)
- 81 Development of a computer method for volumetric response assessment in mesothelioma (2006) (5)
- Confirmation of high prevalence of BAP1 inactivation in mesothelioma. (2015) (5)
- Automated segmentation of mesothelioma volume on CT scan (2005) (5)
- How Effective Is Neoadjuvant Therapy Followed by Surgery for Pathologic Single-Station N2 Non-Small Cell Lung Cancer? (2020) (5)
- Performance Comparison between SURPAS and ACS NSQIP Surgical Risk Calculator in Pulmonary Resection. (2020) (5)
- SMART or simply bold? (2016) (4)
- Improved Preoperative Risk Assessment Tools Are Needed to Guide Informed Decision Making before Esophagectomy (2020) (4)
- A Phase III Randomized Trial of Pleurectomy/Decortication Plus Chemotherapy With or Without Adjuvant Hemithoracic Intensity-Modulated Pleural Radiation Therapy (IMPRINT) for Malignant Pleural Mesothelioma (MPM) (NRG LU-006). (2020) (4)
- Current surgical therapy for stage IIIA (N2) non-small cell lung cancer. (2011) (4)
- Estimation of the likelihood of epidermal growth factor receptor (EGFR) mutations based on cigarette smoking history in patients with adenocarcinoma of the lung (2005) (4)
- Overexpression of Cyclins D 1 and E Is Frequent in Bronchial Preneoplasia and Precedes Squamous Cell Carcinoma Development 1 (1999) (4)
- P2.04-88 Surgical Outcomes of a Multicenter Phase II Trial of Neoadjuvant Atezolizumab in Resectable Stages IB-IIIB NSCLC: Update on LCMC3 Clinical Trial (2019) (4)
- Morbidity and mortality for pulmonary resections in lung cancer after induction treatment (2000) (4)
- Post-mastectomy angiosarcoma: case report and review of the literature. (1984) (4)
- Artificial intelligence (AI)–powered pathologic response (PathR) assessment of resection specimens after neoadjuvant atezolizumab in patients with non-small cell lung cancer: Results from the LCMC3 study. (2021) (4)
- Thoracic surgeons and clinical trials: a manifesto for the future. (1992) (4)
- Long-term assessment of efficacy with a novel Thoracic Survivorship Program for patients with lung cancer (2021) (4)
- Thoracic surgical clinical trials: Y2K and beyond. (1999) (4)
- Modification of Pathological T Classification for Non-small Cell Lung Cancer with Visceral Pleural Invasion: Data from 1,055 Cases of Cancers 3 cm or Less. (2021) (4)
- Amiodarone with or without N-Acetylcysteine for the Prevention of Atrial Fibrillation after Thoracic Surgery: A Double-blind, Randomized Trial (2022) (4)
- Lung Cancer Workup and Staging (2010) (4)
- The challenge of malignant pleural mesothelioma: new directions. (2014) (4)
- High-resolution computed tomography in clinical T1 N0 M0 adenocarcinoma of the lung. (2002) (4)
- A phase II study of atezolizumab as neoadjuvant and adjuvant therapy in patients (pts) with resectable non-small cell lung cancer (NSCLC). (2017) (3)
- A phase II study of intrapleural immunochemotherapy, pleurectomy/decortication, radiotherapy, systemic chemotherapy, and long-term subcutaneous IL-2 in stage II-III malignant pleural mesothelioma. (2007) (3)
- Resection of stage III non-small cell lung cancer following induction therapy (1995) (3)
- ED05.02 Update on the Mesothelioma Staging System (2017) (3)
- Decreased PET SUV after induction chemotherapy is associated with improved survival in malignant pleural mesothelioma (MPM) (2005) (3)
- Exchanging double-lumen for single-lumen endotracheal tubes after thoracotomy. (1991) (3)
- Propensity-matched Analysis Demonstrates Long-term Risk of Respiratory and Cardiac Mortality After Pneumonectomy Compared With Lobectomy for Lung Cancer (2020) (3)
- Therapeutic sentinel lymph node imaging. (2009) (3)
- Reflex testing of lung adenocarcinomas for EGFR and KRAS mutations: The Memorial Sloan-Kettering experience (2008) (3)
- Brief Report: Multimodality Therapy in Patients with Primary Pericardial Mesothelioma. (2022) (3)
- A Randomized Phase II Trial of Adjuvant Galinpepimut-S, WT-1 Analog Peptide Vaccine, after Multimodality Therapy for Patients with Malignant Pleural Mesothelioma (2017) (3)
- Pleurectomy and Decortication: How I Teach It. (2017) (3)
- Initial Experience With Lung Cancer Resection Following Treatment With T Cell Checkpoint Inhibitor Therapy (2017) (3)
- Systemic and oligo-acquired resistance to PD-(L)1 blockade in lung cancer. (2022) (3)
- D2-01: Prospective trial of preoperative gefitinib to correlate response with EGFR exon 19 and 21 mutations and to select patients for adjuvant gefitinib (2007) (3)
- Abstract CT079: Neoadjuvant PD-1 blockade in resectable lung cancer (2018) (3)
- Modification of Pathologic T Classification for Non-small Cell Lung Cancer With Visceral Pleural Invasion (2021) (3)
- MA04.10 Comprehensive Peripheral Blood Immunophenotyping and T-Cell Clonal Analysis During Neoadjuvant Immunotherapy with Atezolizumab in NSCLC (2018) (3)
- Primary lung cancer in women after previous breast cancer (2021) (2)
- O-29 The methylthioadenosine phosphorylase (MTAP) gene is homozygously co-deleted with CDKN2A in most pleural mesotheliomas. Detection by fluorescent in situ hybridization (FISH) and by immunohistochemistry (IHC) using a novel MTAP monoclonal antibody (2003) (2)
- Transcutaneous Cardiac Pacing during Thoracic Surgery Feasibility and Hemodynamic Evaluation by Transesophageal Echocardiography (1993) (2)
- Resected Lung Cancer Patients Who Would and Would Not Have Met Screening Criteria. (2016) (2)
- Role of PET scan in predicting response to neoadjuvant chemotherapy and long-term outcomes for stage II lung cancer. (2014) (2)
- PREVALENCE AND MORTALITY OF ACUTE LUNG INJURY AND ACUTE RESPIRATORY DISTRESS SYNDROME AFTER LUNG RESECTION (2005) (2)
- Safety of hemithoracic pleural intensity-modulated radiation therapy (IMRT) for malignant pleural mesothelioma (MPM) in the multimodality setting: Interim analysis of a phase II study (2013) (2)
- Real-time intraoperative tissue oxygenation monitoring by wireless pulse oximetry (WiPOX) to assess gastric conduit oxygenation during esophagogastrectomy: A prospective feasibility study (2011) (2)
- A prospective trial of intraoperative tissue oxygenation measurement and its association with anastomotic leak rate after Ivor Lewis esophagectomy (2020) (2)
- Surgical Results of the Lung Cancer Mutation Consortium 3 (LCMC 3) Trial: (2022) (2)
- Recent Clinical Experience with Multimodality Therapy in Thymic Carcinoma: P1-128 (2007) (2)
- A Phase III Randomized Trial of Pleurectomy/Decortication Plus Chemotherapy With Or Without Adjuvant Hemithoracic Intensity-Modulated Pleural Radiation Therapy (IMPRINT) For Malignant Pleural Mesothelioma (MPM) (NRG-LU006) (2020) (2)
- Video-atlas of extrapleural pneumonectomy. (2012) (2)
- Resection and Mediastinal Lymph Node Dissection (2005) (2)
- Toxicity and Outcomes of Thoracic Re-irradiation Using Stereotactic Body Radiation Therapy: Improved Local Control with BED ≥ 100 Gy (2011) (2)
- DNA Damage and Repair Capacity in Lung Cancer Patients: Prediction of Multiple Primary Tumors (2015) (2)
- 174 Multicenter phase II trial of neoadjuvant pemetrexed plus cisplatin (PC) followed by extrapleural pneumonectomy (EPP) and radiation (RT) for malignant pleural mesothelioma (MPM) (2005) (2)
- Recent clinical experience with multimodality therapy in thymic carcinoma (2007) (2)
- O-075 Malignant pleural mesothelioma (MPM): New predictors ofsurvival and an analysis of the impact of current treatment (2005) (2)
- Can induction chemotherapy improve dysphagia in locally advanced esophageal/GEJ cancer? (2014) (2)
- Surgery and Postoperative Radiotherapy (2005) (2)
- 2152 Phase II trial of combined surgical resection, high dose rate intraoperative radiation therapy, and external beam radiotherapy for malignant pleural mesothelioma (1997) (1)
- Hemithoracic radiation therapy and brachytherapy after pleurectomy/decortication for malignant pleural mesothelioma: Results from a 30-year experience (2005) (1)
- The IASLC Lung Cancer Staging Project: Overview of Challenges and Opportunities in Revising the Nodal Classification of Lung Cancer. (2022) (1)
- Bronchoscopic Treatment of Bronchopleural and Tracheoesophageal Fistulas Using Silver Nitrate and Dehydrated Alcohol (2011) (1)
- E05-03: Proposals for the revision of the n descriptors in the TNM classification for lung cancer: the IASLC lung cancer staging project (2007) (1)
- Nodal metastases in non-small cell lung cancer: Hop, skip, or jump? (2015) (1)
- The IASLC Lung Cancer Staging Project: Methods and Guiding Principles for the Development of the 9th Edition TNM Classification. (2022) (1)
- Mesothelin-targeted T Cells Gene-Engineered with 4-1BB Costimulation Overcome Tumor-Mediated Immunoinhibition and Eradicate Established Solid Tumors (2014) (1)
- Reply to Waller et al. Standardizing Surgical Treatment for Mesothelioma. (2020) (1)
- 50th Anniversary Perspective on Volume 1: Urschel HC, Paulson DL. Mesotheliomas of the Pleura. Ann Thorac Surg 1965;1:559-73. (2015) (1)
- Patterns and influence of nodal metastases after neoadjuvant chemoradiation and R0 resection in esophageal adenocarcinoma. (2022) (1)
- Metastatic Neoplasms to the Lung: Introduction (2002) (1)
- PET scan-directed chemoradiation (CRT) for esophageal squamous cell carcinoma (ESCC): No benefit for salvage chemo in PET non-responders (PETnr). (2018) (1)
- 52 – Lung Metastases (2014) (1)
- Therapeutic options for the treatment of advanced lung cancer: introduction. (2008) (1)
- Regressions 14 days following bevacizumab as a single agent as part of neoadjuvant chemotherapy for resectable non???squamous NSCLC: P3-097 (2007) (1)
- Surgery for non-small cell lung cancer. (2001) (1)
- O-078 Gene expression profiling of malignant mesothelioma forprognostic prediction and identification of potential therapeutic targets and differential diagnostic markers (2005) (1)
- Five decades of progress in surgical oncology: Tumors of the lung and esophagus (2022) (1)
- Outcomes of indwelling tunneled pleural catheters for malignant pleural effusion: The role for surgical evaluation (2010) (1)
- Evolving Landscape of Initial Treatments for Patients with Malignant Pleural Mesotheliomas: Clinical Trials to Clinical Practice (2022) (1)
- Integrated genomic analysis of lung adenocarcinomas identifies loss of the MAPK phosphatase gene DUSP4 in most EGFR mutant tumors (2007) (1)
- Lymph nodes in lung cancer: location, location, and location? (2015) (1)
- Povidone iodine: the new solution for mesothelioma? (2015) (1)
- Does endoscopy accurately predict response to chemoradiation in patients undergoing esophagectomy? (2006) (1)
- P3-097: Regressions 14 days following bevacizumab as a single agent as part of neoadjuvant chemotherapy for resectable non–squamous NSCLC (2007) (1)
- Use of SUVmax to predict response to neoadjuvant chemoradiotherapy in patients with adenocarcinoma of the distal esophagus and GE Junction (2008) (1)
- High-intensity sequencing reveals the sources of plasma circulating cell-free DNA variants (2019) (1)
- Thoracic and Cardiovascular (2003) (1)
- Effect of EGFR and IGF1R on feedback activation of AKT arising from inhibition of mTOR in malignant pleural mesothelioma (MPM). (2010) (1)
- P1.01-122 A Clinical Utility Study of Plasma DNA Next Generation Sequencing Guided Treatment of Uncommon Drivers in Advanced Non-Small-Cell Lung Cancers (2019) (1)
- Interim Analysis of a Phase 2 Toxicity Study on Hemithoracic Pleural Intensity Modulated Radiation Therapy (IMRT) for Malignant Pleural Mesothelioma (MPM) (2013) (1)
- Frequency of use and outcome of surgical resection in the management of malignant mesothelioma in a community-based population: Results in 5,937 patients. (2016) (1)
- A multicenter phase II toxicity study of lung-sparing intensity modulated radiation therapy (IMRT) for malignant pleural mesothelioma (MPM). (2014) (1)
- Neoadjuvant atezolizumab in resectable NSCLC patients: Updated clinical and immunophenotyping results from a multicenter trial. (2019) (1)
- Abstract B27: A preclinical mouse model of orthotopic pleural cancer that facilitates noninvasive quantitative monitoring of tumor progression and therapy response (2009) (1)
- EGFR and KRAS mutation status of lung adenocarcinomas in African Americans. (2009) (1)
- Induction FOLFOX and PET-Directed Chemoradiation for Locally Advanced Esophageal Adenocarcinoma (2021) (1)
- Are there imaging characteristics that can distinguish separate primary lung carcinomas from intrapulmonary metastases using next-generation sequencing as a gold standard? (2021) (1)
- Aggressive Surgery for Lung Cancer (2004) (1)
- WE-FG-206-06: Dual-Input Tracer Kinetic Modeling and Its Analog Implementation for Dynamic Contrast-Enhanced (DCE-) MRI of Malignant Mesothelioma (MPM). (2016) (1)
- Tumor volumetric correlation with plasma cell free DNA (cfDNA) mutation detection in metastatic lung cancers. (2019) (1)
- Factors influencing outcome after pulmonary resection for colorectal cancer (CRC) metastases in the current era (2008) (1)
- Women leaders in (colorectal) surgery: Can the extraordinary become ordinary? (2020) (1)
- TECHNIQUE OF EXTRAPLEURAL PNEUMONECTOMY FOR MALIGNANT PLEURAL MESOTHELIOMA (2008) (1)
- Use of integrated genomic analysis to evaluate BRCA-associated protein 1 (BAP1) as a mutated gene in malignant pleural mesothelioma (MPM). (2010) (1)
- SCCRO oncogenicity modulated by interaction with CAND1/CULLIN (2006) (1)
- O-202 Adjuvant therapy, stage and tumor histology impact prognosis after resection of malignant pleural mesothelioma (2003) (1)
- Phase II study of docetaxel and vinorelbine as adjuvant chemotherapy for resected non-small cell lung cancers (2013) (1)
- Should we reestablish the Lung Cancer Study Group? (1994) (1)
- Association of BAP1 alterations with malignant pleural mesothelioma treated with trimodality therapy. (2019) (1)
- S 008 – Real-time intraoperative detection of tissue hypoxia in gastrointestinal surgery by Wireless Pulse Oximetry ( WiPOX ) (2017) (1)
- 856 NODAL METASTASES AFTER NEOADJUVANT CHEMORADIATION AND R0 RESECTION IN ESOPHAGEAL ADENOCARCINOMA: PATTERNS AND PROGNOSIS (2021) (0)
- Microarray gene expression analysis of cells isolated from malignant pleural effusions (MPE) from patients with non-small cell lung cancer (NSCLC). (2004) (0)
- Commentary: Germ cell serum tumor markers: The canary in the coal mine? (2020) (0)
- PD5-3-8: Development of a non-small cell lung cancer (NSCLC) survivorship program: baseline clinical characteristics and quality of life (QOL) (2007) (0)
- Analysis of prognostic factors in southwest oncology group stage III non-small cell lung cancer trials requiring pre-treatment histological assessment of mediastinal lymph nodes (2002) (0)
- Book Review Mesothelioma Edited by Bruce W.S. Robinson and A. Philippe Chahinian. 366 pp., illustrated. London, Martin Dunitz, 2002. $145. 9-05823-180-1 (2004) (0)
- High-dose hemithoracic radiation therapy following extrapleural pneumonectomy in 32 patients treated at the memorial sloan-kettering cancer center for malignant pleural mesothelioma (2001) (0)
- P2.06-019 A Phase II Study of Atezolizumab as Neoadjuvant and Adjuvant Therapy in Patients (pts) with Resectable Non-Small Cell Lung Cancer (NSCLC): Topic: Phase II + NK (2017) (0)
- Local therapy for oligoprogression in NSCLC patients being treated with osimertinib (2019) (0)
- O-31 18FDG-PET SUV: Prognostic value for surgically treated lung cancer (2003) (0)
- Outcomes of Percutaneous Drainage Versus Subxiphoid Pericardial Window for the Treatment of Pericardial Effusions in the Cancer Population (2011) (0)
- Commentary: Outcomes after esophagectomy: The devil is in the details. (2021) (0)
- Thoracoscopic Management of Chest Neoplasms (1994) (0)
- Brief Report: Contralateral Lobectomy for Second Primary NSCLC: Perioperative and Long-Term Outcomes (2022) (0)
- Genomic and transcriptomic analysis of a diffuse pleural mesothelioma patient-derived xenograft library (2022) (0)
- ROBOTIC-ASSISTED VIDEO-ASSISTED THORACIC SURGERY LOBECTOMY (2008) (0)
- 762. Cisplatin-Induced DNA Damage Repair Mechanism Potentiates the Synergistic Efficacy of Oncolytic Herpes Simplex Viral Therapy in the Treatment of Malignant Mesothelioma (2005) (0)
- Pancoast Tumors and Combined Spinal Resections (2011) (0)
- ATRIAL FIBRILLATION FOLLOWING THORACIC SURGERY: ROLE OF CALCIUM CHANNEL ACTIVATION (1999) (0)
- Use of PET-measured response in involved mediastinal lymph nodes to predict overall survival (OS) in non-small cell lung cancer (NSCLC) patients treated with induction therapy (IT) and surgery. (2010) (0)
- Initial results of pulmonary resection following neoadjuvant nivolumab in patients with resectable non-small cell lung cancer (2019) (0)
- ideo-assisted thoracic surgery does not reduce the ncidence of postoperative atrial fibrillation after ulmonary lobectomy (2007) (0)
- Invited commentary. (2011) (0)
- American College of Surgeons NSQIP Surgical Risk Calculator Performs Well in Pulmonary Resection: A Validation Study (2019) (0)
- The Current Status and Future Direction of Surgical Treatments for Lung Cancer (2010) (0)
- Commentary: Surgical standardization in mesothelioma trials. (2021) (0)
- Invited commentary. (2014) (0)
- TRAUMATIC RUPTURE OF THE THORACIC AORTA IN PEDIATRIC PATIENTS (1989) (0)
- Oncolytic herpes simplex viral therapy effectively treats and improves survival in a murine model of pleural malignant mesothelioma (2004) (0)
- Identifying City-Level Esophageal Cancer Disparities to Guide Future Targeted Intervention (2019) (0)
- Liquid biopsy in the clinic: A prospective study of plasma circulating tumor DNA (ctDNA) next generation sequencing (NGS) in patients with advanced non-small cell lung cancers to match targeted therapy. (2017) (0)
- Mesothelin Expression Promotes An Aggressive Phenotype Of Non-Small Cell Lung Cancer (NSCLC) (2011) (0)
- A Prospective Clinical Trial to Evaluate Mesothelin as a Biomarker for the Clinical Management of Patients with Esophageal Adenocarcinoma (2023) (0)
- Heart Dosimetry is Correlated with Risk of Radiation Pneumonitis after Lung-Sparing Hemithoracic Pleural IMRT for Malignant Pleural Mesothelioma (2017) (0)
- The possibility of molecular targeted therapy in patients with pulmonary large cell neuroendocrine carcinoma. (2010) (0)
- Thoracic Track Abstracts (2011) (0)
- O-017 Lung adenocarcinomas with mutations in EGFR and KRAS havedistinct gene expression profiles (2005) (0)
- 161 Phase II trial of combined surgical resection, intraoperative high dose rate brachytherapy (IORT), and external beam radiation therapy (ESRT) for malignant pleural mesothelioma (MPM) (1996) (0)
- Quantitating pathologic response to neoadjuvant chemotherapy in KRAS-mutated versus nonmutated lung cancers. (2012) (0)
- Key to Our Clinical Care. (2022) (0)
- IL-5 Advances in the multimodality treatment of lung cancer (2007) (0)
- Invited commentary. (2013) (0)
- Localization ofBronchial Intraepithelial Neoplastic Lesions byFluorescence Bronchoscopy (2017) (0)
- O-123 A prospective study to correlate EGFR mutations with gefitinib response in early stage NSCLC (2005) (0)
- Abstract 3375: Ultrasensitive ctDNA minimal residual disease monitoring in early NSCLC with PhasED-Seq (2023) (0)
- Invited commentary. (2015) (0)
- Small cell carcinoma of the esophagus: Review of the Memorial Sloan-Kettering Cancer Center (MSKCC) experience (2007) (0)
- O-105 Simultaneous bilateral thoracotomy for resection of bilateral pulmonary metastases: A safe and effective approach (2003) (0)
- TARGETED AND CELL-BASED THERAPIES (2014) (0)
- Central Review of Contours and Treatment Plans for Hemithoracic Intensity-Modulated Pleural Radiation Therapy (IMPRINT) – Implementation and Lessons Learned from a Prospective Multicenter Phase II Study (2019) (0)
- Surgical results for mesothelioma: Implications for a new staging system (1997) (0)
- Constitutive genetic instability in patients with multiple, primary non-small cell lung cancers (2005) (0)
- The Accuracy of Intraoperative Cytologic Evaluation during Endobronchial Ultrasound-Guided Transbronchial Needle Aspiration for Mediastinal and Hilar Lymphadenopathy. (2009) (0)
- Circulating tumor DNA in advanced lung cancers: A prospective evaluation of matched therapy and shedding detection. (2018) (0)
- Prospective study of tumor suppressor gene (TSG) methylation as a prognostic biomarker in surgically resected non-small cell lung cancer (NSCLC). (2012) (0)
- SCCRO/DCUN1D-gene family is commonly dysregulated in non-small cell lung cancers (2008) (0)
- Tu1591 Learning Curve for Combined Thoracoscopic and Laparoscopic Robotic-Assisted Minimally Invasive Esophagectomy Using a Four-Arm Platform (2014) (0)
- Commentary (Flores/Rusch): Diffuse Malignant Mesothelioma of the Pleural Space and Its Management (2002) (0)
- Mutational profiling of the oncogenome in non-small cell lung cancer (NSCLC) (2005) (0)
- FDG-PET scan after induction chemotherapy for esophageal squamous cell cancer (ESCC) to predict for outcomes after chemoradiation (chemoRT) and to guide salvage chemotherapy during RT. (2014) (0)
- Esophageal Cancer : Associations With ( pN þ ) e Metastases Lymph Nod (2017) (0)
- Translating Telemedicine to Thoracic Surgical Oncological Care: Performance Analysis and Patient Perceptions During the COVID-19 Pandemic. (2022) (0)
- Outcomes With Local Therapy and Tyrosine Kinase Inhibition in Patients With ALK/ROS1/RET-Rearranged Lung Cancers. (2021) (0)
- Surgical Staging of Lung Cancer for Advances in Radiation Oncology of Lung Cancer (2011) (0)
- Factors contributing to the development of mitomycin induced interstitial pneumonitis after thoracic surgery (1992) (0)
- O-185 CT and FDG PET characteristics of bronchoalveolar carcinoma (2003) (0)
- Reply to “Cancer Staging Correspondence 2” (2008) (0)
- A Phase 1 Safety Study of Avelumab Plus Stereotactic Body Radiation Therapy in Malignant Pleural Mesothelioma (2022) (0)
- Prevalence of germline BAP1 mutations in patients with malignant mesothelioma (MM). (2014) (0)
- Comments on the proposed new international lymph node international association for the study of lung cancer map (2009) (0)
- Postoperative fluorescence bronchoscopic surveillance: a worthwhile procedure in a subset of patients: Reply (2002) (0)
- The Thoracic Surgery Service at Memorial Sloan Kettering Cancer Center. (2015) (0)
- The Role of Surgical Resection Following Primary Chemoradiation Therapy in Esophageal Squamous Cell Carcinoma: A Decision Analysis (2011) (0)
- Prognostic significance of a diagnosis of multiple lung cancers. (2015) (0)
- Disparities in Early-Stage Lung Cancer Diagnosis Before and after Implementation of Screening Guidelines (2019) (0)
- OA01.03 Impact of Increasing Age on Cause-Specific Mortality and Morbidity in Stage I NSCLC Patients: A Competing Risk Analysis (2017) (0)
- Operative Time Is Associated with Postoperative Complications After Pulmonary Lobectomy. (2022) (0)
- Radiotherapy Treatment Planning for Patients with Malignant Pleural Mesothelioma (MPM) using 18-FDG Positron Emission Tomography (PET) (2008) (0)
- Patient-reported symptom frequency and distress after open and minimally invasive esophagectomy. (2015) (0)
- Minimal residual local disease predicts improved survival after chemoradiotherapy in patients with squamous cell carcinoma of the esophagus (2007) (0)
- ES 05.02 Superior Sulcus Tumor (2017) (0)
- F-123QUALITY OF LIFE AND PAIN OUTCOMES AFTER ROBOTIC-ASSISTED MINIMALLY INVASIVE OESOPHAGECTOMY AND OPEN OESOPHAGECTOMY: SHORT-TERM RESULTS OF A PROSPECTIVE TRIAL (2015) (0)
- cDNA screening to identify genes correlated with SCCRO-associated angiogenesis and metastasis in squamous cell carcinoma of the lung. (2004) (0)
- P-285 Tissue microarray (TMA) of mediastinoscopy specimens to assess the p53 pathway in stage IIIA non-small cell lung cancer: Impact on outcome in patients treated with pre-operative chemotherapy (2003) (0)
- Mesothelin is a biomarker of tumor aggressiveness and therapy response in malignant pleural mesothelioma (MPM) (2010) (0)
- Correlative analysis from a phase I clinical trial of intrapleural administration of oncolytic vaccinia virus (Olvi-vec) in patients with malignant pleural mesothelioma (2023) (0)
- En Bloc Resection of Thoracic Tumors Involving the Spine (2007) (0)
- OA 10.03 Liquid Biopsy in the Lung Cancer Clinic: A Prospective Study of Plasma DNA next Generation Sequencing to Guide Matched Therapy (2017) (0)
- FIGURE 1. Median survival of patients with and without EPP. (2013) (0)
- Novel noninvasive measurement of total tumor glycolysis by PET predicts survival after complete surgical resection of NSCLC. (2004) (0)
- Advanced age is associated with lack of administration of adjuvant chemotherapy for completely resected stage IB-III non-small cell lung cancer (NSCLC): PD4-2-8 (2007) (0)
- Surgical results of the Lung Cancer Mutation Consortium 3 trial: A phase II multicenter single-arm study to investigate the efficacy and safety of atezolizumab as neoadjuvant therapy in patients with stages IB-select IIIB resectable non-small cell lung cancer. (2022) (0)
- Successful Incorporation of a Peri-operative Pulmonary Rehabilitation Program for Patients Following Thoracic Surgery. From Evidence-based Medicine to Clinical Practice. (2007) (0)
- Postoperative Pulmonary Complications after Neoadjuvant Chemoradiotherapy with IMRT for Esophageal Cancer (2010) (0)
- P-933 Selective use of a rigid prosthesis for chest wall reconstructionafter chest wall resection reduces respiratory complication rates (2005) (0)
- Q 16-1 LUNG CANCER WORKUP AND STAGING (2015) (0)
- Improved Preoperative Risk Assessment Is Needed to Guide Informed Decision Making Before Esophagectomy (2019) (0)
- Improved survival among patients with malignant pleural mesotheliomas who develop immune-related adverse events on immunotherapy. (2021) (0)
- Distinct Differences in Gastroesophageal Junction and Gastric Adenocarcinoma in 2194 Patients (2021) (0)
- O-054 Genetic instability, response to DNA damage, and repair capacity in individuals with multiple primary non-small cell lung cancers (2005) (0)
- PD4-2-8: Advanced age is associated with lack of administration of adjuvant chemotherapy for completely resected stage IB-III non-small cell lung cancer (NSCLC) (2007) (0)
- PUB017 Minimally Invasive Lobectomy is Associated with Lower Noncancer Mortality in Elderly: A Propensity-Score Matched Analysis (2017) (0)
- Long-Term Resul ts of Combined-Modal i ty Therapy in Resectable Non – Smal l-Cel l Lung Cancer (2002) (0)
- Next generation sequencing (NGS) in lung adenocarcinoma (LA) as a guide to treatment selection. (2016) (0)
- Initiating the Era of "Precision" Lung Cancer Surgery. (2023) (0)
- 903 Outcomes of well-differentiated papillary peritoneal mesothelioma (2015) (0)
- AB009. OS02.03. Phase II trial of cetuximab and chemotherapy followed by surgical resection for locally advanced thymoma (2017) (0)
- A1177 INTRAOPERATIVE FIO2AND THE DEVELOPMENT OF MITOMYCIN-INDUCED POST-OPERATIVE INTERSTITIAL PNEUMONITIS (1990) (0)
- MTP3-01: Robotic-assisted VATS lobectomy (2007) (0)
- PD5-3-7: EGFR and KRAS mutations are molecular predictors of survival in resected lung adenocarcinoma (2007) (0)
- Department of Error (2006) (0)
- Comparison of Sex Differences in Patients Undergoing Resection for Lung Cancer: Time to Move beyond the One-Size-Fits-All Approach (2019) (0)
- O-025KRAS MUTATION PREDICTS WORSE OVERALL SURVIVAL IN CLINICAL STAGE IIIA LUNG ADENOCARCINOMA PATIENTS TREATED WITH INDUCTION CHEMOTHERAPY FOLLOWED BY SURGERY (2015) (0)
- for bronchioloalveolar carcinoma Clinical pattern and pathologic stage but not histologic features predict outcome (2013) (0)
- MESOTHELIOMA : AN INCURABLE, NONSURGICALLY TREATABLE DISEASE. AUTHOR'S REPLY (1993) (0)
- Nael Martini: a leader in thoracic surgical oncology. (2010) (0)
- Extended restrictions for lung cancer : chest-wall and pancoast tumors (2014) (0)
- Female gender is an independent predictor of superior perioperative survival following non-small cell lung cancer (NSCLC) resection. (2006) (0)
- 228 MET in mesothelioma: Mutational screening, phosphorylation status, and sensitivity to the MET inhibitor PHA-665752 (2006) (0)
- 2651 Trimodality Treatment using Integrated Chemoradiation with Surgery for Locally Advanced, Non-small Cell Lung Cancer (LA-NSCLC) (2008) (0)
- P-690 EGFR and KRAS mutational analysis of mucinous pneumonicbronchiololavelolar carcinomas (2005) (0)
- Effect of furosemide on fully established low pressure pulmonary edema. (1988) (0)
- Changing chemotherapy (C) with concurrent radiation (RT) followed by surgery after sub-optimal FDG-PET response to induction chemotherapy improves outcomes in locally advanced (LA) esophageal adenocarcinoma (EA). (2015) (0)
- Resection of primary nonseminomatous germ cell tumors of the anterior mediastinum: A 28-year experience at Memorial Sloan-Kettering Cancer Center (2009) (0)
- Initial Experience With Lung thereafter were deemed appropriate for lung cancer Cancer Resection After Treatment With T-Cell Checkpoint Inhibitors (2017) (0)
- Introduction to gender editorials (2004) (0)
- Erratum: Evidence against a role for SV40 infection in human mesotheliomas and high risk of false-positive PCR results owing to presence of SV40 sequences in common laboratory plasmids (Lancet (2004) 364 (1157-1166)) (2005) (0)
- Clinicopathologic outcomes of preoperative targeted therapy in patients with clinical stage I to III non-small cell lung cancer. (2022) (0)
- Whole B ody 18 FDG-PET a nd t he R esponse o f E sophageal Cancer t o I nduction T herapy: R esults o f a P rospective T rial (2003) (0)
- Staging of Mesothelioma (2005) (0)
- Waiting to Operate (2023) (0)
- Commentary: Is glue the key to success in malignant pleural mesothelioma? (2019) (0)
- OA 03.03 Phase II Trial of Cetuximab and Chemotherapy Followed by Surgical Resection for Locally Advanced Thymoma (2017) (0)
- PD-124 Survival after mechanical ventilation for complications after pneumonectomy (2005) (0)
- Next generation sequencing (NGS) in resectable non-small cell lung cancer (NSCLC): Therapeutic implications. (2016) (0)
- PET-directed chemoradiation (CRT) with induction FOLFOX compared to induction carboplatin/paclitaxel (CP) in patients with locally advanced esophageal adenocarcinoma (EA). (2020) (0)
- Impact of pre-operative chemoradiotherapy on post-esophagectomy morbidity and mortality. (2006) (0)
- Commentary: Assessing tumor stage and treatment response in pleural mesothelioma: Are pleural thickness measurements the new standard? (2023) (0)
- Neurofibromatosis Type 2-Yes-Associated Protein and Transcriptional Coactivator With PDZ-Binding Motif Dual Immunohistochemistry Is a Reliable Marker for the Detection of Neurofibromatosis Type 2 Alterations in Diffuse Pleural Mesothelioma. (2023) (0)
- Perioperative pharmacotherapy for lung resection: "Going for the gold"? (2016) (0)
- Absence of SV40 RNA casts doubt on its association with mesothelioma (2004) (0)
- Comprehensivegenomiccharacterization of squamous cell lung cancers (2012) (0)
- Abstract 3229: Biomarker validation for a rare malignancy in a mouse model (2010) (0)
- The association of PET response with complete pathological response (CPR) and residual nodal disease (RND) after induction chemoradiotherapy (CRT) and resection of esophageal cancer: A review of 493 cases. (2009) (0)
- 922 CT and MRI staging of malignant pleural mesothelioma: Correlation with surgical/pathologic results (1997) (0)
- Induction chemotherapy, extrapleural pneumonectomy (EPP), and adjuvant hemithoracic radiation are feasible and effective for locally advanced malignant pleural mesothelioma (MPM). (2004) (0)
- Abstract 14523: N-acetylcysteine for the Prevention of Atrial Fibrillation After Noncardiac Thoracic Surgery: A Double-blind, Randomized, Placebo-controlled Trial (2020) (0)
- Reply to D. de Fonseka et al. (2018) (0)
- Abstract CT215: Efficacy and safety of adjuvant (adj) atezolizumab (atezo) from the Phase 2 LCMC3 study (2023) (0)
- Spray Cryotherapy for Malignant Airway Obstruction: A Single Institutional Experience (2011) (0)
- Intensity Modulated Hemithoracic Radiation Therapy for Malignant Pleural Mesothelioma (MPM) after Pleurectomy/Decortication (2007) (0)
- Mutational analysis of EGFR signaling pathway genes in lung adenocarcinomas (2007) (0)
- Is routine chest radiography necessary after endobronchial ultrasound-guided fine needle aspiration? (2020) (0)
- 103 An integrated genomic approach to understanding the determinants of mesothelioma sensitivity to specific novel agents (2006) (0)
This paper list is powered by the following services:
Other Resources About Valerie Rusch
What Schools Are Affiliated With Valerie Rusch?
Valerie Rusch is affiliated with the following schools:
